Wednesday Jul 8 | American Chronicle
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has new updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
Wednesday Jul 8 | GlobeNewswire
Foresight Biotherapeutics Announces FST-100 Displays Robust Clinical...
Foresight Biotherapeutics, Inc. today announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis.
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
EMERYVILLE, Calif. and HUENENBERG, Switzerland, July 5 CA-Alcon-NovaBay-Trl EMERYVILLE, Calif.
The Amateur Economist & Curmudgeon Blog
The first piece is particularly good, and brief. ;-) Socialize medical care? - by Dr.
11 cases of measles in Brooklyn
The health department has identified 11 cases of measles in Brooklyn during the past two months and is urging doctors to be vigilant and promptly report suspected cases to the agency.
Sun Pharmaceutical Industries Ltd announces USFDA tentative approval for generic Optivar
MUMBAI, India, July 2, 2009: Sun Pharmaceutical Industries Ltd. announced receipt of a tentative approval from USFDA for Sun Pharma's Abbreviated New Drug Application for generic Optivar, azelastine ophthalmic solution, 0.05%. This sterile azelastine hydrochloride ophthalmic solution is therapeutically equivalent to Optivar Ophthalmic Solution, ...
Newborn ICUs Seeing More Antibiotic-Resistant Staph Infections
The rate of methicillin-resistant Staphylococcus aureus infections in U.S. neonatal intensive care units has more than tripled in recent years, reports a study in the July issue of The Pediatric Infectious Disease Journal .
See a sample reprint in PDF format. Order a reprint of this article now LIFE & STYLE JULY 1, 2009, 12:27 A.M. ET Patients Visit With Their Physicians Online as More Insurers Begin Paying for Digital Diagnoses By ANNA WILDE MATHEWS Jane Rust woke up early one day last year and discovered that her left eye was red, swollen and itchy.
Scientists Receive 4.3 Million For Pioneering Asthma And Allergy-Prevention Research, London
Researchers at St George's, University of London have been awarded A 4.3 million by the Wellcome Trust for the development of a unique new class of drugs to target the root cause of asthma and allergies.
What Is Gonorrhea? What Causes Gonorrhea?
Main Category: Sexual Health / STDs Also Included In: Infectious Diseases / Bacteria / Viruses Article Date: 29 Jun 2009 Gonorrhea is a sexually transmitted bacterial infection that tends to attack the mucous membranes of the body.
An eye infection is a relatively general description of a medical condition that may result in discomfort, discharge and abnormal appearance of a dog's eyes and surrounding tissue.
Stocks on the move: Chico's FAS, China Bio Energy, Ista, Tibco
Shares of the following companies are having unusual moves in U.S. trading this morning.
ISTA Pharmaceuticals, Inc. Wins US Panel Support for Eye Itch Drug
ISTA Pharmaceuticals, Inc. today announced the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the U.S. Food and Drug Administration recommended the approval of Bepreve 1.5% as an eye drop treatment for ocular itching associated with allergic conjunctivitis.
Bausch & Lomb Canada Introduces PrLotemax™ and PrAlrex
Lotemax and Alrex are now available by prescription in Canada. Canadians can now benefit from the proven efficacy and safety record of these two unique ocular steroids used by millions of patients for over 10 years.1 Lotemax, indicated for the treatment of post-operative inflammation following cataract surgery, is the number one branded ocular ...
FDA says Ista Pharmaceuticals' eye drug Bepreve did not...
Federal health scientists said Wednesday an anti-itching drug from eye care company Ista Pharmaceuticals did not show any serious side effects in testing on patients.
Clinical Trials Update: June 23, 2009
Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com : Conjunctivitis, Bacterial If you have conjunctivitis, you may qualify for this study.
Minor Eye Problems in the Elderly
W. Steven Pray, PhD, DPh Bernhardt Professor, Nonprescription Products and Devices College of Pharmacy Southwestern Oklahoma State University Weatherford, Oklahoma US Pharm.
Don't get ill when your kids do
As a mum, the last thing you want is to get sick. So here's how to avoid the bugs when your child brings them home.
FDA Approves Canakinumab for Rare Inflammatory Disorders
Novartis on Thursday announced the approval of canakinumab, or Ilaris, for the treatment of the cryopyrin-associated periodic syndromes known as familial cold autoinflammatory syndrome and Muckle-Wells syndrome in patients age four years or older.
New Biological Therapy Ilaris(R) Approved In US To Treat Children And ...
Main Category: Immune System / Vaccines Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials The U.S. Food and Drug Administration has approved Ilaris for the treatment of children and adults with cryopyrin-associated periodic syndrome , which includes a number of rare, but life-long, auto-inflammatory disorders with ...